Most sold healthcare stocks in Q1 2021
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2021, measured as net reductions in reported share positions from Q4 2020 into Q1 2021. Notable reductions at the top of this list include MERCK & CO. INC. (MRK), BRISTOL-MYERS SQUIBB CO (BMY), PACIFIC BIOSCIENCES OF CALIF (PACB), ABBVIE INC (ABBV). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| MRK | MERCK & CO. INC. | -9,785,162 | $28.27M | 2 | 10 | 6 | 2 | 21 |
| BMY | BRISTOL-MYERS SQUIBB CO | -7,843,577 | $11.34M | 2 | 9 | 7 | 0 | 21 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -7,688,874 | -$13.09K | 2 | 0 | 2 | 0 | 4 |
| ABBV | ABBVIE INC | -7,329,204 | $1.55M | 1 | 8 | 6 | 2 | 19 |
| FOLD | AMICUS THERAPEUTICS INC | -6,678,788 | -$154.21K | 0 | 0 | 0 | 1 | 0 |
| BSX | BOSTON SCIENTIFIC CORP | -6,004,129 | $2.31M | 1 | 1 | 3 | 2 | 5 |
| VTRS | VIATRIS INC | -5,147,874 | -$5.89M | 1 | 2 | 6 | 1 | 10 |
| CERS | CERUS CORP | -4,187,873 | -$52.41K | 0 | 0 | 2 | 0 | 2 |
| TMDX | TRANSMEDICS GROUP INC | -3,499,859 | -$69.65K | 0 | 0 | 0 | 1 | 0 |
| EXEL | EXELIXIS INC | -3,096,565 | -$382.87K | 0 | 0 | 1 | 2 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -2,771,352 | -$145.54K | 0 | 2 | 2 | 0 | 5 |
| EHC | ENCOMPASS HEALTH CORP | -2,626,716 | -$217.25K | 0 | 1 | 0 | 1 | 1 |
| CI | THE CIGNA GROUP | -2,570,520 | $6.25M | 1 | 0 | 6 | 0 | 9 |
| HUM | HUMANA INC | -2,440,049 | -$546.24K | 0 | 1 | 2 | 1 | 4 |
| CNC | CENTENE CORP | -2,406,186 | $2.27M | 0 | 2 | 2 | 2 | 4 |
| REGN | REGENERON PHARMACEUTICALS | -2,069,561 | $751.00K | 1 | 4 | 1 | 2 | 6 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,010,030 | -$1.04M | 0 | 0 | 3 | 2 | 4 |
| XRAY | DENTSPLY SIRONA INC | -1,934,981 | $1.17M | 0 | 1 | 5 | 1 | 6 |
| MCRB | SERES THERAPEUTICS INC | -1,857,107 | -$92.36K | 0 | 1 | 1 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | -1,579,759 | $162.58K | 0 | 0 | 1 | 0 | 1 |
| CLLS | CELLECTIS - ADR | -1,561,551 | -$77.31K | 0 | 0 | 1 | 0 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | -1,519,796 | -$3.00M | 0 | 3 | 5 | 2 | 8 |
| VCYT | VERACYTE INC | -1,318,092 | -$27.42K | 1 | 0 | 1 | 0 | 2 |
| NVS | NOVARTIS AG-SPONSORED ADR | -1,314,207 | -$686.45K | 1 | 4 | 3 | 1 | 9 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -1,212,910 | -$8.85K | 0 | 0 | 1 | 0 | 1 |
| BKD | BROOKDALE SENIOR LIVING INC | -1,149,000 | $12.12K | 0 | 1 | 1 | 0 | 2 |
| MTNB | MATINAS BIOPHARMA HOLDINGS I | -1,078,759 | -$1.51K | 0 | 0 | 1 | 0 | 1 |
| GERN | GERON CORP | -982,500 | -$1.56K | 0 | 0 | 0 | 1 | 0 |
| CVS | CVS HEALTH CORP | -975,113 | $6.37M | 2 | 11 | 3 | 2 | 18 |
| ONVO | ORGANOVO HOLDINGS INC | -949,765 | -$13.91K | 0 | 0 | 2 | 0 | 2 |
| AMRN | AMARIN CORP PLC -ADR | -933,501 | $298.42K | 1 | 0 | 1 | 0 | 2 |
| EDIT | EDITAS MEDICINE INC | -917,714 | -$323.17K | 1 | 0 | 1 | 0 | 2 |
| ENZ | ENZO BIOCHEM INC | -848,479 | $1.16K | 0 | 0 | 2 | 0 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -791,095 | -$4.27K | 0 | 0 | 1 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | -789,965 | $1.45M | 0 | 1 | 3 | 0 | 6 |
| LAB | STANDARD BIOTOOLS INC | -745,300 | -$4.47K | 0 | 0 | 0 | 1 | 0 |
| OVID | OVID THERAPEUTICS INC | -722,507 | -$29.36K | 0 | 0 | 0 | 2 | 0 |
| OMI | OWENS & MINOR INC | -714,000 | $5.63K | 0 | 0 | 1 | 0 | 1 |
| RVP | RETRACTABLE TECHNOLOGIES INC | -697,100 | -$6.86K | 0 | 0 | 1 | 0 | 1 |
| GMAB | GENMAB A/S -SP ADR | -695,399 | -$37.19K | 0 | 1 | 1 | 1 | 2 |
| LXRX | LEXICON PHARMACEUTICALS INC | -682,500 | -$1.57K | 0 | 0 | 1 | 0 | 1 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | -618,397 | -$52.63K | 0 | 0 | 1 | 1 | 1 |
| CTMX | CYTOMX THERAPEUTICS INC | -611,932 | -$2.29K | 0 | 0 | 1 | 0 | 1 |
| BLUE | BLUEBIRD BIO INC | -603,700 | -$26.12K | 0 | 0 | 0 | 1 | 0 |
| CORT | CORCEPT THERAPEUTICS INC | -567,700 | -$35.65K | 0 | 0 | 1 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | -558,400 | -$23.12K | 0 | 0 | 1 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | -553,927 | $2.18M | 1 | 2 | 3 | 0 | 6 |
| OPK | OPKO HEALTH INC | -542,423 | -$2.08K | 0 | 1 | 0 | 2 | 2 |
| CPIX | CUMBERLAND PHARMACEUTICALS | -530,832 | -$1.49K | 0 | 1 | 1 | 0 | 2 |
| BAX | BAXTER INTERNATIONAL INC | -528,091 | $327.75K | 0 | 0 | 6 | 1 | 10 |
Frequently asked questions about Most sold healthcare stocks in Q1 2021
What are the most sold Healthcare stocks in Q1 2021?
The most sold healthcare stocks in Q1 2021 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2021?
Among filers in this sector, net reductions were largest in companies such as MERCK & CO. INC. (MRK), BRISTOL-MYERS SQUIBB CO (BMY), PACIFIC BIOSCIENCES OF CALIF (PACB), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2020).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.